Madrigal Pharmaceuticals names new CFO amid growth phase By Investing.com
Madrigal Pharmaceuticals names new CFO amid growth phase…
258,900€
2,90%
Echtzeit-Aktienkurs Madrigal Pharmaceuticals
Bid:
Ask:
Nachrichten zur Madrigal Pharmaceuticals Aktie
Madrigal Pharmaceuticals Appoints Mardi C. Dier as Chief Financial Officer
CONSHOHOCKEN, Pa., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical company pursuing novel…